The role of adjuvant chemotherapy in the treatment of adult soft tissue sarcomas

Critical Reviews in Oncology/Hematology

Volumn 27, Issue 3, 1998, Pages 221-227

  O'Byrne, K ^a   Steward, W P ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DACARBAZINE; DACTINOMYCIN; DOXORUBICIN; IFOSFAMIDE; METHOTREXATE; VINCRISTINE;

BONE MARROW SUPPRESSION; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CARDIOTOXICITY; CLINICAL TRIAL; DRUG CHOICE; HUMAN; INJECTION PAIN; INTRAARTERIAL DRUG ADMINISTRATION; LIMB TUMOR; NAUSEA; REVIEW; SOFT TISSUE SARCOMA; TREATMENT OUTCOME; TREATMENT PLANNING; VOMITING;

EID: 0032053080     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1040-8428(98)00004-3     Document Type: Article

References (30)

1. [1] Romsdahl MM, Lindberg RD, Martin RG. Patterns of failure after treatment of soft tissue sarcoma. Cancer Treat Symp 1983;2:251-8.
2. [2] Suit HD. Patterns of failure after treatment of sarcoma of soft tissue by radical surgery or by conservative surgery and radiation. Cancer Treat Symp 1983;2:241-6.
3. [3] vanGeel AN, Pastorino U, Jauch ICW, et al. Surgical treatment of lung metastases: the EORTC Soft Tissue and Bone Sarcoma Group study of 255 patients. Cancer 1996;77:675-82.
4. [4] Verweij J, vanOosterom AT, Somers R, et al. Chemotherapy in the multidisciplinary approach to soft tissue sarcomas. Ann Oncol 1992;3:S75-80.
5. [5] O'Bryan RM, Baker LH, Gottlieb JE, et al. Dose response evaluation of adriamycin in human neoplasia. Cancer 1977;39:1940-8.
6. [6] Bramwell VHC, Mouridsen HT, Mulder JH, et al. Carminomycin versus Adriamycin in advanced soft tissue sarcoma. An EORTC randomised Phase II study. Eur J Cancer 1983;19:1097-104.
7. [7] Dombernowsky P, Mouridsen H, Nielsen OS, et al. A phase III study comparing adriamycin versus two schedules of high dose epirubicin in advanced soft tissue sarcoma. Proc Am Soc Clin Oncol 1995;14:515.
8. [8] Stuart-Harris RC, Harper PG, Parsons CA, et al. High dose alkylating therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft tissue sarcoma. Cancer Chemother Pharmacol 1983;11:69-72.
9. [9] Bramwell VHC, Mouridsen HT, Santoro A, et al. Cyclophosphamide versus Ifosfamide: final report of a randomised phase II trial in adult soft tissue sarcoma. Eur J Cancer 1987;23:311-21.
10. [10] Le Cesne A, Spielmann AM, LeChevalier T, et al. High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas. J Clin Oncol 1995;13:1600-8.
11. [11] Gottlieb JA, Benjamin RS, Baker LH, et al. Role of DTIC (NSC 45388) in the chemotherapy of sarcomas. Cancer Treat Rep 1976;60:199-203.
12. [12] Verweij J, Mouridsen HT, Nielssen OS, et al. The present state of the art in chemotherapy for soft tissue sarcomas in adults: the EORTC point of view. Crit Rev Oncol Hematol 1995;20:193-201.
13. [13] Santoro A, Tursz T, Mouridsen H, et al. Doxorubicin versus CyVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomised study of the EORTC Soft Tissue and Bone Sarcoma Group. J Clin Oncol 1995;13:1537-45.
14. [14] Tierney JF, Mosseri V, Stewart LA, Souhami RL, Parmar MKB. Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomised clinical trials. Br J Cancer 1995;72:469-75.
15. [15] Antman K, Amato D, Lerner H, et al. Adjuvant doxorubicin for sarcoma: Data from the ECOG and DFCI/MGH studies. Cancer Treat Symp 1985;3:109-15.
16. [16] Antman K, Ryan L, Borden E, et al. Pooled results from three randomized adjuvant studies of doxorubicin versus observation in soft tissue sarcoma: 10-year results and review of literature. In: Salmon SE, editor. Adjuvant Therapy of Cancer, vol. VI. Philadelphia: WB Saunders, 1990:529-43.
17. [17] Wilson RE, Wood WC, Lerner HL, et al. Doxorubicin chemotherapy in the treatment of soft tissue sarcoma: Combined results of two randomized trials. Arch Surg 1986;121:1354-9.
18. [18] Alvegard TA, Sigurdsson H, Mouridsen H, et al. Adjuvant chemotherapy with doxorubicin in high grade soft tissue sarcomas: A randomized trial of the Scandinavian Sarcoma Group. J Clin Oncol 1989;7:1504-13.
19. [19] Edmonson JH, Fleming TR, Ivans JC, et al. A randomized study of systemic chemotherapy following complete excision of non-osseous sarcomas. J Clin Oncol 1984;2:1390-6.
20. [20] Bramwell V, Rouésse J, Steward W, et al. Adjuvant CyVADIC chemotherapy for adult soft tissue sarcoma - Reduced local recurrence but no improvement in survival: A study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol 1994;12:1137-49.
21. [21] Gherlinzoni F, Bacci G, Picci P, et al. A randomized trial for the treatment of high grade soft tissue sarcomas of the extremities: Preliminary observations. J Clin Oncol 1986;4:552-8.
22. [22] Eilber FR, Giuliano AE, Huth JF, Morton DL. A randomized prospective trial using postoperative chemotherapy (adriamycin) in high grade extremity soft-tissue sarcoma. Am J Clin Oncol (CCT) 1988;11:39-45.
23. [23] Chang AE, Kinsella T, Glastein E, et al. Adjuvant chemotherapy for patients with high grade soft tissue sarcomas of the extremity. J Clin Oncol 1988;6:1491-500.
24. [24] Benjamin RS, Terjanian TO, Genoglio CJ, Barkley HT, Evans HC, Murphy WK, Martin RG. The importance of combination chemotherapy for adjuvant treatment of high risk patients with soft tissue sarcomas of the extremities. In: Salmon SE, editor. Adjuvant Therapy, vol. V. New York: Grune and Stratton, 1987:735-44.
25. [25] Glenn J, Kinsella T, Galstein E, et al. A randomized, perspective trial of adjuvant chemotherapy in adults with soft tissue sarcomas of the head and neck, breast and trunk. Cancer 1985;55:1206-14.
26. [26] Omura GA, Blessing JA, Major F, et al. A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: A Gynaecologic Oncology Group Study. J Clin Oncol 1985;3:1240-5.
27. [27] Ravaud A, Bui NB, Coindre JM, et al. Adjuvant chemotherapy with CyVADIC in high risk soft tissue sarcoma: A randomized prospective trial. In: Salmon SE, editor. Adjuvant Therapy of Cancer, vol. VI. Philadelphia: WB Saunders, 1990:556-66.
28. [28] Jones GW, Chouinard E, Patel M. Adjuvant adriamycin (doxorubicin) in adult patients with soft-tissue sarcomas: A systematic overview and quantitative meta-analysis (abstract). Clin Invest Med 1991;14 (Suppl 19):A772.
29. [29] Sarcoma Meta-Analysis Collaboration. Adjuvant chemotherapy for localised resectable soft tissue sarcomas of adults: meta-analysis of individual data. Lancet 1997 1997;350:1647-54.
30. [30] Steward WP, Verweij J, Somers R, et al. Granulocyte -macrophage colony-stimulating factor allows safe escalation of dose-intensity of chemotherapy in metastatic adult soft tissue sarcomas: A study of the EORTC Soft Tissue and Bone Sarcoma Group. J Clin Oncol 1993;11:15-21.